Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
Related structures:
AlphaFold database: E9B5A0
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 162 | 164 | PF00675 | 0.560 |
CLV_NRD_NRD_1 | 85 | 87 | PF00675 | 0.720 |
CLV_PCSK_KEX2_1 | 10 | 12 | PF00082 | 0.463 |
CLV_PCSK_KEX2_1 | 112 | 114 | PF00082 | 0.598 |
CLV_PCSK_KEX2_1 | 162 | 164 | PF00082 | 0.560 |
CLV_PCSK_KEX2_1 | 51 | 53 | PF00082 | 0.745 |
CLV_PCSK_KEX2_1 | 85 | 87 | PF00082 | 0.637 |
CLV_PCSK_PC1ET2_1 | 10 | 12 | PF00082 | 0.423 |
CLV_PCSK_PC1ET2_1 | 112 | 114 | PF00082 | 0.598 |
CLV_PCSK_PC1ET2_1 | 51 | 53 | PF00082 | 0.799 |
CLV_PCSK_PC1ET2_1 | 85 | 87 | PF00082 | 0.637 |
CLV_PCSK_SKI1_1 | 193 | 197 | PF00082 | 0.588 |
CLV_PCSK_SKI1_1 | 37 | 41 | PF00082 | 0.406 |
CLV_PCSK_SKI1_1 | 59 | 63 | PF00082 | 0.793 |
DEG_APCC_DBOX_1 | 178 | 186 | PF00400 | 0.398 |
DEG_ODPH_VHL_1 | 185 | 197 | PF01847 | 0.342 |
DOC_MAPK_DCC_7 | 88 | 98 | PF00069 | 0.404 |
DOC_MAPK_gen_1 | 19 | 27 | PF00069 | 0.566 |
DOC_MAPK_MEF2A_6 | 19 | 27 | PF00069 | 0.550 |
DOC_PP1_RVXF_1 | 35 | 41 | PF00149 | 0.415 |
DOC_USP7_MATH_1 | 129 | 133 | PF00917 | 0.360 |
DOC_USP7_UBL2_3 | 65 | 69 | PF12436 | 0.564 |
DOC_WW_Pin1_4 | 43 | 48 | PF00397 | 0.388 |
LIG_14-3-3_CanoR_1 | 19 | 24 | PF00244 | 0.546 |
LIG_14-3-3_CanoR_1 | 86 | 91 | PF00244 | 0.499 |
LIG_Actin_WH2_2 | 148 | 164 | PF00022 | 0.360 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.690 |
LIG_BRCT_BRCA1_1 | 174 | 178 | PF00533 | 0.360 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.380 |
LIG_FHA_1 | 133 | 139 | PF00498 | 0.162 |
LIG_FHA_1 | 156 | 162 | PF00498 | 0.288 |
LIG_FHA_1 | 20 | 26 | PF00498 | 0.453 |
LIG_FHA_1 | 4 | 10 | PF00498 | 0.760 |
LIG_FHA_1 | 48 | 54 | PF00498 | 0.519 |
LIG_FHA_2 | 221 | 227 | PF00498 | 0.303 |
LIG_FHA_2 | 238 | 244 | PF00498 | 0.516 |
LIG_LIR_Gen_1 | 121 | 130 | PF02991 | 0.333 |
LIG_LIR_Gen_1 | 203 | 209 | PF02991 | 0.398 |
LIG_LIR_Gen_1 | 26 | 36 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 121 | 125 | PF02991 | 0.333 |
LIG_LIR_Nem_3 | 26 | 31 | PF02991 | 0.358 |
LIG_Pex14_1 | 110 | 114 | PF04695 | 0.301 |
LIG_SH2_CRK | 42 | 46 | PF00017 | 0.461 |
LIG_SH2_PTP2 | 122 | 125 | PF00017 | 0.374 |
LIG_SH2_SRC | 122 | 125 | PF00017 | 0.344 |
LIG_SH2_STAP1 | 114 | 118 | PF00017 | 0.398 |
LIG_SH2_STAT5 | 114 | 117 | PF00017 | 0.325 |
LIG_SH2_STAT5 | 122 | 125 | PF00017 | 0.325 |
LIG_SH2_STAT5 | 141 | 144 | PF00017 | 0.360 |
LIG_SH3_1 | 88 | 94 | PF00018 | 0.445 |
LIG_SH3_3 | 88 | 94 | PF00018 | 0.422 |
LIG_SUMO_SIM_anti_2 | 95 | 101 | PF11976 | 0.360 |
LIG_SUMO_SIM_par_1 | 21 | 26 | PF11976 | 0.542 |
LIG_SUMO_SIM_par_1 | 223 | 228 | PF11976 | 0.360 |
LIG_UBA3_1 | 98 | 107 | PF00899 | 0.357 |
MOD_CDK_SPK_2 | 43 | 48 | PF00069 | 0.398 |
MOD_CK1_1 | 105 | 111 | PF00069 | 0.297 |
MOD_CK1_1 | 132 | 138 | PF00069 | 0.438 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.677 |
MOD_CK1_1 | 92 | 98 | PF00069 | 0.435 |
MOD_CK2_1 | 208 | 214 | PF00069 | 0.406 |
MOD_CK2_1 | 220 | 226 | PF00069 | 0.282 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.722 |
MOD_GlcNHglycan | 104 | 107 | PF01048 | 0.357 |
MOD_GlcNHglycan | 53 | 56 | PF01048 | 0.678 |
MOD_GlcNHglycan | 75 | 78 | PF01048 | 0.661 |
MOD_GSK3_1 | 15 | 22 | PF00069 | 0.512 |
MOD_GSK3_1 | 196 | 203 | PF00069 | 0.435 |
MOD_GSK3_1 | 43 | 50 | PF00069 | 0.628 |
MOD_GSK3_1 | 51 | 58 | PF00069 | 0.655 |
MOD_LATS_1 | 49 | 55 | PF00433 | 0.477 |
MOD_N-GLC_1 | 139 | 144 | PF02516 | 0.442 |
MOD_N-GLC_1 | 172 | 177 | PF02516 | 0.438 |
MOD_N-GLC_1 | 81 | 86 | PF02516 | 0.496 |
MOD_NEK2_1 | 102 | 107 | PF00069 | 0.318 |
MOD_NEK2_1 | 134 | 139 | PF00069 | 0.415 |
MOD_NEK2_1 | 15 | 20 | PF00069 | 0.664 |
MOD_NEK2_1 | 161 | 166 | PF00069 | 0.403 |
MOD_NEK2_1 | 237 | 242 | PF00069 | 0.635 |
MOD_PIKK_1 | 71 | 77 | PF00454 | 0.664 |
MOD_PK_1 | 196 | 202 | PF00069 | 0.435 |
MOD_PKA_1 | 112 | 118 | PF00069 | 0.492 |
MOD_PKA_1 | 51 | 57 | PF00069 | 0.689 |
MOD_PKA_1 | 86 | 92 | PF00069 | 0.613 |
MOD_PKA_2 | 112 | 118 | PF00069 | 0.492 |
MOD_PKA_2 | 132 | 138 | PF00069 | 0.162 |
MOD_PKA_2 | 161 | 167 | PF00069 | 0.391 |
MOD_PKA_2 | 51 | 57 | PF00069 | 0.658 |
MOD_Plk_1 | 172 | 178 | PF00069 | 0.238 |
MOD_Plk_4 | 105 | 111 | PF00069 | 0.280 |
MOD_Plk_4 | 118 | 124 | PF00069 | 0.346 |
MOD_Plk_4 | 220 | 226 | PF00069 | 0.397 |
MOD_Plk_4 | 23 | 29 | PF00069 | 0.492 |
MOD_Plk_4 | 92 | 98 | PF00069 | 0.477 |
MOD_ProDKin_1 | 43 | 49 | PF00069 | 0.486 |
TRG_DiLeu_BaLyEn_6 | 10 | 15 | PF01217 | 0.425 |
TRG_DiLeu_BaLyEn_6 | 34 | 39 | PF01217 | 0.415 |
TRG_ENDOCYTIC_2 | 114 | 117 | PF00928 | 0.438 |
TRG_ENDOCYTIC_2 | 122 | 125 | PF00928 | 0.438 |
TRG_ENDOCYTIC_2 | 204 | 207 | PF00928 | 0.444 |
TRG_ENDOCYTIC_2 | 42 | 45 | PF00928 | 0.587 |
TRG_ER_diArg_1 | 130 | 133 | PF00400 | 0.438 |
TRG_ER_diArg_1 | 161 | 163 | PF00400 | 0.438 |
TRG_NLS_MonoCore_2 | 84 | 89 | PF00514 | 0.605 |
TRG_NLS_MonoExtC_3 | 84 | 90 | PF00514 | 0.551 |
TRG_Pf-PMV_PEXEL_1 | 183 | 188 | PF00026 | 0.415 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P5F6 | Leptomonas seymouri | 57% | 98% |
A0A3R7RME9 | Trypanosoma rangeli | 30% | 100% |
A0A3S7X8C5 | Leishmania donovani | 88% | 97% |
A4HB30 | Leishmania braziliensis | 70% | 100% |
A4IA87 | Leishmania infantum | 89% | 97% |
C9ZM16 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 29% | 100% |
Q4Q2N3 | Leishmania major | 90% | 100% |